A Brouwer1, H-T Nguyen2, F J Snoek3, D H van Raalte4, A T F Beekman1, A C Moll2, M A Bremmer1. 1. Department of Psychiatry, Amsterdam Public Health research institute, VU University Medical Center and GGZ inGeest, Amsterdam, The Netherlands. 2. Department of Ophthalmology, VU University Medical Center, Amsterdam, The Netherlands. 3. Departments of Medical Psychology, Amsterdam Public Health research institute, VU University Medical Center and Academic Medical Center, Amsterdam, The Netherlands. 4. Diabetes Center, VU University Medical Center, Amsterdam, The Netherlands.
Abstract
OBJECTIVE: Light therapy has become an increasingly popular treatment for depression and a range of other neuropsychiatric conditions. Yet, concerns have been raised about the ocular safety of light therapy. METHOD: We conducted the first systematic review into the ocular safety of light therapy. A PubMed search on January 4, 2017, identified 6708 articles, of which 161 were full-text reviewed. In total, 43 articles reporting on ocular complaints and ocular examinations were included in the analyses. RESULTS: Ocular complaints, including ocular discomfort and vision problems, were reported in about 0% to 45% of the participants of studies involving light therapy. Based on individual studies, no evident relationship between the occurrence of complaints and light therapy dose was found. There was no evidence for ocular damage due to light therapy, with the exception of one case report that documented the development of a maculopathy in a person treated with the photosensitizing antidepressant clomipramine. CONCLUSION: Results suggest that light therapy is safe for the eyes in physically healthy, unmedicated persons. The ocular safety of light therapy in persons with preexisting ocular abnormalities or increased photosensitivity warrants further study. However, theoretical considerations do not substantiate stringent ocular safety-related contraindications for light therapy.
OBJECTIVE: Light therapy has become an increasingly popular treatment for depression and a range of other neuropsychiatric conditions. Yet, concerns have been raised about the ocular safety of light therapy. METHOD: We conducted the first systematic review into the ocular safety of light therapy. A PubMed search on January 4, 2017, identified 6708 articles, of which 161 were full-text reviewed. In total, 43 articles reporting on ocular complaints and ocular examinations were included in the analyses. RESULTS: Ocular complaints, including ocular discomfort and vision problems, were reported in about 0% to 45% of the participants of studies involving light therapy. Based on individual studies, no evident relationship between the occurrence of complaints and light therapy dose was found. There was no evidence for ocular damage due to light therapy, with the exception of one case report that documented the development of a maculopathy in a person treated with the photosensitizing antidepressant clomipramine. CONCLUSION: Results suggest that light therapy is safe for the eyes in physically healthy, unmedicated persons. The ocular safety of light therapy in persons with preexisting ocular abnormalities or increased photosensitivity warrants further study. However, theoretical considerations do not substantiate stringent ocular safety-related contraindications for light therapy.
Authors: José A Rubiño; Antoni Gamundí; Mourad Akaarir; Francesca Canellas; Rubén Rial; M Cristina Nicolau Journal: Front Neurosci Date: 2020-05-06 Impact factor: 4.677
Authors: Carlo Volf; Anne Sofie Aggestrup; Paul Michael Petersen; Carsten Dam-Hansen; Ulla Knorr; Ema Erkocevic Petersen; Janus Engstrøm; Janus C Jakobsen; Torben Skov Hansen; Helle Østergaard Madsen; Ida Hageman; Klaus Martiny Journal: BMJ Open Date: 2020-01-26 Impact factor: 2.692
Authors: Carlo Volf; Anne Sofie Aggestrup; Signe Dunker Svendsen; Torben Skov Hansen; Paul Michael Petersen; Carsten Dam-Hansen; Ulla Knorr; Ema Erkocevic Petersen; Janus Engstrøm; Ida Hageman; Janus Christian Jakobsen; Klaus Martiny Journal: Pilot Feasibility Stud Date: 2020-01-15